Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Genmab is seeking a Senior CMC Writer to support global regulatory submissions across our expanding portfolio. You will transform complex CMC information into clear, compliant documents and independently drive writing activities while mentoring colleagues.
Based in Copenhagen, you will work with cross-functional teams, apply AI/digital tools to improve documentation, and ensure timely delivery across BLAs, MAAs, NDAs and related filings.
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
Genmab’s CMC Writing team is growing, and we are looking for a Senior CMC Writer to support global regulatory submissions across our expanding portfolio.
Your primary focus will be documentation for global Biologics License Applications (BLAs), Marketing Authorisation Applications (MAAs), New Drug Applications (NDAs), and responses to health authority questions during assessment. Working closely with scientific and technical experts, you will transform complex CMC information into clear, accurate, and consistent regulatory submission documents.
You will join a dedicated team of CMC writers collaborating across early and late-stage development, regulatory submission, and lifecycle management. As a senior colleague, you will independently drive writing activities, provide expert review and mentoring, and help improve documentation practices through AI and digital tools.
The position reports to the Director, Head of CMC Writing, and is based in Copenhagen, Denmark.
Your responsibilities include:
You hold a master’s degree in science or a related technical discipline. An advanced degree, relevant certification, or equivalent experience is preferred.
You bring at least six years of experience in CMC or a related field within the pharmaceutical, biotechnology, and/or medical device industry, with relevant experience in biologics and/or chemical development and manufacturing. We welcome candidates with backgrounds in biologics, small molecules, or both.
The proposed gross annual/hourly base salary range for this position, in the primary location, based on a full time schedule is:
DKK624.000,00---936.000,00
The final salary offer will depend on several factors, including your skills, qualifications, and experience.
In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.
Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).